Publications by authors named "Xavier Cahu"

Claim this Profile
H
How should we diagnose and treat blastic plasmacytoid dendritic cell neoplasm patients?
Francine Garnache-Ottou, Chrystelle Vidal, Sabeha Biichlé, Florian Renosi, Eve Poret, Xavier Cahu

Blood Adv· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bone marrow sites differently imprint dormancy and chemoresistance to T-cell acute lymphoblastic leukemia.
Xavier Cahu, Julien Calvo, Sandrine Poglio, Nais Prade, Benoit Colsch

Blood Adv· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of body-surface area on patients' outcome in younger adults with acute myeloid leukemia.
Xavier Cahu, Martin Carré, Christian Recher, Arnaud Pigneux, Mathilde Hunault-Berger

Eur J Haematol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uncoupling JAK2 V617F activation from cytokine-induced signalling by modulation of JH2 αC helix.
Emilie Leroy, Alexandra Dusa, Didier Colau, Amir Motamedi, Xavier Cahu

Biochem J· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncogenic Drivers in Myeloproliferative Neoplasms: From JAK2 to Calreticulin Mutations.
Xavier Cahu, Stefan N Constantinescu

Curr Hematol Malig Rep· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Peripheral Blood Plasmacytoid Dendritic Cells at Day 100 Can Predict Outcome after Allogeneic Stem Cell Transplantation.
Zinaida Peric, Xavier Cahu, Florent Malard, Eolia Brissot, Patrice Chevallier

Biol Blood Marrow Transplant· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Initial fluconazole prophylaxis may not be required in adults with acute leukemia or myelodysplastic/myeloproliferative disorders after reduced intensity conditioning peripheral blood stem cell allogeneic transplantation.
Eolia Brissot, Xavier Cahu, Thierry Guillaume, Jacques Delaunay, Sameh Ayari

Ann Hematol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interleukin-18 produced by bone marrow-derived stromal cells supports T-cell acute leukaemia progression.
Benjamin Uzan, Sandrine Poglio, Bastien Gerby, Ching-Lien Wu, Julia Gross, Xavier Cahu

EMBO Mol Med· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic hematopoietic stem cell transplantation following reduced-intensity conditioning regimen in children: a single-center experience.
Marion Strullu, Fanny Rialland, Xavier Cahu, Eolia Brissot, Nadege Corradini

Eur J Haematol· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fludarabine, antithymocyte globulin, and very low-dose busulfan for reduced-intensity conditioning before allogeneic stem cell transplantation in patients with lymphoid malignancies.
Florent Malard, Xavier Cahu, Aline Clavert, Eolia Brissot, Patrice Chevallier

Biol Blood Marrow Transplant· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cutaneous macroglobulinosis treated with bortezomib and rituximab.
Tony Marchand, Patrick Tas, Roch Houot, Charles Dauriac, Thierry Lamy, Xavier Cahu

Eur J Haematol· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infectious complications after unrelated umbilical cord blood transplantation in adult patients with hematologic malignancies.
Xavier Cahu, Fanny Rialland, Cyrille Touzeau, Patrice Chevallier, Thierry Guillaume

Biol Blood Marrow Transplant· December 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis